The California Life Sciences Association today said it inked a deal with Orange County life science and tech accelerator OCTANe to “accelerate the growth of Orange County’s life sciences sector.”
Through the deal, the CLSA will provide multi-faceted support to OCTANe stakeholders, including state and federal advocacy services, public policy roundtables and industry programs and conferences.
“We are thrilled to further extend our statewide resources and capabilities into Orange County to intensify the investment and innovation in their life sciences cluster. California’s life sciences ecosystem, as exemplified in and around Orange County, is driving the economy and delivering life-changing medicines and technologies that benefit overall health and well-being. For the sector to continue flourishing, we need to strengthen and facilitate life sciences research, investment and entrepreneurship to move new ideas forward. This collaboration aims to empower both CLSA and OCTANe members by providing key statewide resources and tools necessary to succeed,” CLSA CEO & prez Sara Radcliffe said in a press release.
Members of OCTANe will also be eligible to use CLSA’s business solutions program, which includes $100 million in funds and discounts on services from lab supplies to healthcare benefits, the groups said.
“Considering the demands of Southern California’s emerging life sciences industry, this partnership with the California Life Sciences Association is based on the simple notion of providing companies what they want in order to grow and expand their business. This alliance is further proof of OCTANe’s mission to connect people and ideas with resources and capital. By providing this additional suite of services to our early-stage companies, we will support the sustained growth of our thriving life sciences community,” OCTANe CEO Bill Carpou said in prepared remarks.
“This partnership shines a brighter light on the important work happening in Orange County’s life sciences community, which is impacting patients all around the world, and allows emerging life sciences companies the opportunity to participate in state and federal legislation as part of the greater voice of California’s biomedical industry,” Edwards Lifesciences strategy & corp dev corporate veep Donald Bobo, Jr. said in a prepared release.
In February, OCTANe said it launched the Visionary Venture Fund and Advisory Board, a $50 million venture fund that aims to boost ophthalmology innovation and development in Orange County, Calif. and in the wider medical industry.
The fund will support select startup companies through both monetary support and counsel from experts in the ophthalmology field, according to Aliso Viejo, Calif.-based OCTANe. More than 20 ophthalmology industry experts will aid later-stage startups in navigating from the initial funding and development stages through to commercialization.